{"id":{"repo_id":"uthsc","oai_identifier":"oai:digitalcommons.library.tmc.edu:utgsbs_dissertations-1746"},"canonical_url":"https://search.dev.ndltd.org/etd/uthsc/oai:digitalcommons.library.tmc.edu:utgsbs_dissertations-1746","repository":{"repo_id":"uthsc","name":"University of Texas Health Science Center at Houston","base_url":"https://digitalcommons.library.tmc.edu/do/oai/"},"display":{"title":"Understanding The Mechanism and Extent of Vlse Recombination In Borrelia Burgdorferi Using Next-Generation Sequencing","abstract":"<p><em>B.</em> <em>burgdorferi</em>, the causative agent of Lyme disease, have an elaborate antigenic variation system that involves varying the sequence of <em>vlsE. </em>Previous studies have shown that <em>vlsE</em> antigenic variation occurs continuously inside mammalian hosts. Variation has not been shown previously to occur in<em> in vitro</em> or in ticks. We hypothesized that the induction of <em>vlsE</em> recombination requires contact with dense arrays of host tissue cells and/or ECM components. To test this hypothesis, two methods, quantitative PCR and high-throughput sequencing were used determine the extent and nature of <em>vlsE </em>recombination within mouse tissues and <em>in vitro</em> model systems. Using these approaches, we were able to detect<em> vlsE</em> variants in axenic cultures of <em>B. burgdorferi</em> as well as co-cultures with mouse skin and heart tissues; these results were compared with those from mice infected for 7 days. Analysis of PacBio single molecule real-time (SMRT) sequencing indicated the presence of 0.84% to 1.18% variants in pure<em> in vitro </em>cultures and 0.79% to 1.22% in tissue explants, as compared 36% to 57% for organisms from mouse bladder tissue 7 days post inoculation. Statistical evaluation of the variants showed that the rate of recombination in tissue explants was not significantly different from the rate of recombination in <em>in vitro</em> cultures. Thus, tissue explant co-cultures do not seem to promote a higher recombination rate than in <em>in vitro</em> axenic culture. Moreover, high-throughput PacBio sequencing was found to be an effective means of analyzing single molecule sequencing variation in the robust <em>vlsE </em>antigenic variation system.</p>","abstract_html":"&lt;p&gt;&lt;em&gt;B.&lt;/em&gt; &lt;em&gt;burgdorferi&lt;/em&gt;, the causative agent of Lyme disease, have an elaborate antigenic variation system that involves varying the sequence of &lt;em&gt;vlsE. &lt;/em&gt;Previous studies have shown that &lt;em&gt;vlsE&lt;/em&gt; antigenic variation occurs continuously inside mammalian hosts. Variation has not been shown previously to occur in&lt;em&gt; in vitro&lt;/em&gt; or in ticks. We hypothesized that the induction of &lt;em&gt;vlsE&lt;/em&gt; recombination requires contact with dense arrays of host tissue cells and/or ECM components. To test this hypothesis, two methods, quantitative PCR and high-throughput sequencing were used determine the extent and nature of &lt;em&gt;vlsE &lt;/em&gt;recombination within mouse tissues and &lt;em&gt;in vitro&lt;/em&gt; model systems. Using these approaches, we were able to detect&lt;em&gt; vlsE&lt;/em&gt; variants in axenic cultures of &lt;em&gt;B. burgdorferi&lt;/em&gt; as well as co-cultures with mouse skin and heart tissues; these results were compared with those from mice infected for 7 days. Analysis of PacBio single molecule real-time (SMRT) sequencing indicated the presence of 0.84% to 1.18% variants in pure&lt;em&gt; in vitro &lt;/em&gt;cultures and 0.79% to 1.22% in tissue explants, as compared 36% to 57% for organisms from mouse bladder tissue 7 days post inoculation. Statistical evaluation of the variants showed that the rate of recombination in tissue explants was not significantly different from the rate of recombination in &lt;em&gt;in vitro&lt;/em&gt; cultures. Thus, tissue explant co-cultures do not seem to promote a higher recombination rate than in &lt;em&gt;in vitro&lt;/em&gt; axenic culture. Moreover, high-throughput PacBio sequencing was found to be an effective means of analyzing single molecule sequencing variation in the robust &lt;em&gt;vlsE &lt;/em&gt;antigenic variation system.&lt;/p&gt;","abstract_has_math":false,"creators":["Tyagi, Surabhi"],"institution":null,"degree_name":"Masters of Science (MS)","degree_level":"Thesis (MS)","degree_discipline":null,"degree_department":null,"school":null,"contributors":["Steven Norris","David Volk","Cesas Arias"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2016,"date_issued":"2016-08-01T07:00:00Z","date_published":"2016-08-01T07:00:00Z","updated_at":"2026-07-24T05:49:54Z","subjects":["Medicine and Health Sciences"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"https://digitalcommons.library.tmc.edu/utgsbs_dissertations/702","outbound_label":"Repository record","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Steven Norris","David Volk","Cesas Arias"]},{"key":"dc:creator","label":"Author","values":["Tyagi, Surabhi"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2016-08-16T07:00:00Z"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Thesis (MS)"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Masters of Science (MS)"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Medicine and Health Sciences"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://digitalcommons.library.tmc.edu/utgsbs_dissertations/702"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["<p><em>B.</em> <em>burgdorferi</em>, the causative agent of Lyme disease, have an elaborate antigenic variation system that involves varying the sequence of <em>vlsE. </em>Previous studies have shown that <em>vlsE</em> antigenic variation occurs continuously inside mammalian hosts. Variation has not been shown previously to occur in<em> in vitro</em> or in ticks. We hypothesized that the induction of <em>vlsE</em> recombination requires contact with dense arrays of host tissue cells and/or ECM components. To test this hypothesis, two methods, quantitative PCR and high-throughput sequencing were used determine the extent and nature of <em>vlsE </em>recombination within mouse tissues and <em>in vitro</em> model systems. Using these approaches, we were able to detect<em> vlsE</em> variants in axenic cultures of <em>B. burgdorferi</em> as well as co-cultures with mouse skin and heart tissues; these results were compared with those from mice infected for 7 days. Analysis of PacBio single molecule real-time (SMRT) sequencing indicated the presence of 0.84% to 1.18% variants in pure<em> in vitro </em>cultures and 0.79% to 1.22% in tissue explants, as compared 36% to 57% for organisms from mouse bladder tissue 7 days post inoculation. Statistical evaluation of the variants showed that the rate of recombination in tissue explants was not significantly different from the rate of recombination in <em>in vitro</em> cultures. Thus, tissue explant co-cultures do not seem to promote a higher recombination rate than in <em>in vitro</em> axenic culture. Moreover, high-throughput PacBio sequencing was found to be an effective means of analyzing single molecule sequencing variation in the robust <em>vlsE </em>antigenic variation system.</p>"]},{"key":"dc:title","label":"Title","values":["Understanding The Mechanism and Extent of Vlse Recombination In Borrelia Burgdorferi Using Next-Generation Sequencing"]}]}],"canonical_facts":{"dc:contributor":["Steven Norris","David Volk","Cesas Arias"],"dc:creator":["Tyagi, Surabhi"],"dc:date.available":["2016-08-16T07:00:00Z"],"dc:description.abstract":["<p><em>B.</em> <em>burgdorferi</em>, the causative agent of Lyme disease, have an elaborate antigenic variation system that involves varying the sequence of <em>vlsE. </em>Previous studies have shown that <em>vlsE</em> antigenic variation occurs continuously inside mammalian hosts. Variation has not been shown previously to occur in<em> in vitro</em> or in ticks. We hypothesized that the induction of <em>vlsE</em> recombination requires contact with dense arrays of host tissue cells and/or ECM components. To test this hypothesis, two methods, quantitative PCR and high-throughput sequencing were used determine the extent and nature of <em>vlsE </em>recombination within mouse tissues and <em>in vitro</em> model systems. Using these approaches, we were able to detect<em> vlsE</em> variants in axenic cultures of <em>B. burgdorferi</em> as well as co-cultures with mouse skin and heart tissues; these results were compared with those from mice infected for 7 days. Analysis of PacBio single molecule real-time (SMRT) sequencing indicated the presence of 0.84% to 1.18% variants in pure<em> in vitro </em>cultures and 0.79% to 1.22% in tissue explants, as compared 36% to 57% for organisms from mouse bladder tissue 7 days post inoculation. Statistical evaluation of the variants showed that the rate of recombination in tissue explants was not significantly different from the rate of recombination in <em>in vitro</em> cultures. Thus, tissue explant co-cultures do not seem to promote a higher recombination rate than in <em>in vitro</em> axenic culture. Moreover, high-throughput PacBio sequencing was found to be an effective means of analyzing single molecule sequencing variation in the robust <em>vlsE </em>antigenic variation system.</p>"],"dc:identifier":["https://digitalcommons.library.tmc.edu/utgsbs_dissertations/702"],"dc:subject":["Medicine and Health Sciences"],"dc:title":["Understanding The Mechanism and Extent of Vlse Recombination In Borrelia Burgdorferi Using Next-Generation Sequencing"],"thesis:degree_level":["Thesis (MS)"],"thesis:degree_name":["Masters of Science (MS)"]},"updated_at":"2026-07-24T05:49:54Z"}